{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:16:08Z","timestamp":1790838968370,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.thromres.2008.10.008","type":"journal-article","created":{"date-parts":[[2008,12,8]],"date-time":"2008-12-08T05:27:40Z","timestamp":1228714060000},"page":"862-868","source":"Crossref","is-referenced-by-count":24,"title":["Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: Differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays?"],"prefix":"10.1016","volume":"123","author":[{"given":"Emmanuel J.","family":"Favaloro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Thom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Just","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Koutts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Baccala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Rowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2008.10.008_bib1","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2008.10.008_bib2","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1055\/s-2006-947859","article-title":"Laboratory identification of von Willebrand Disease: Technical and scientific perspectives","volume":"32","author":"Favaloro","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.thromres.2008.10.008_bib3","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1055\/s-2007-1000364","article-title":"An update on the von Willebrand factor collagen binding (VWF:CB) assay: 21\u00a0years of age and beyond adolescence, but not yet a mature adult","volume":"33","author":"Favaloro","year":"2007","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.thromres.2008.10.008_bib4","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1160\/TH06-12-0693","article-title":"2B or not 2B? Disparate discrimination of functional VWF discordance using different assay panels or methodologies may lead to success or failure in the early identification of Type 2B VWD","volume":"98","author":"Favaloro","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2008.10.008_bib5","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1055\/s-2006-947865","article-title":"Reducing errors in identification of von Willebrand disease: The experience of the Royal college of Pathologists of Australasia Quality Assurance Program","volume":"32","author":"Favaloro","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.thromres.2008.10.008_bib6","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1182\/blood-2006-05-020784","article-title":"Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD)","volume":"109","author":"Goodeve","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2008.10.008_bib7","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1538-7836.2006.01860.x","article-title":"Genetic linkage and association analysis in type 1 von Willebrand disease: results from the Canadian type 1 VWD study","volume":"4","author":"James","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2008.10.008_bib8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1182\/blood-2006-05-021105.","article-title":"The mutational spectrum of type 1 von Willebrand disease: Results from a Canadian cohort study","volume":"109","author":"James","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2008.10.008_bib9","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1160\/TH06-07-0383","article-title":"An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease","volume":"96","author":"Cumming","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2008.10.008_bib10","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/ajh.20470","article-title":"von Willebrand disease R1374C: type 2A or 2M? A challenge to the revised classification. High frequency in the northwest of Spain (Galicia)","volume":"80","author":"Penas","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1016\/j.thromres.2008.10.008_bib11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1046\/j.1365-2141.2002.03199.x","article-title":"Use of the collagen-binding assay for von Willebrand factor in the analysis of type 2M von Willebrand disease: a comparison with the ristocetin cofactor assay","volume":"116","author":"Riddell","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2008.10.008_bib12","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1111\/j.1538-7836.2007.02666.x","article-title":"Challenges in defining type 2M von Willebrand disease: results from a Canadian cohort study","volume":"5","author":"James","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2008.10.008_bib13","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1055\/s-2006-947862","article-title":"An external quality assessment program for von Willebrand factor laboratory analysis: an overview from the European concerted action on thrombosis and disabilities foundation","volume":"32","author":"Meijer","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.thromres.2008.10.008_bib14","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1055\/s-2006-947863","article-title":"Laboratory tests for measurement of von Willebrand factor show poor agreement among different centers: results from the United Kingdom National External Quality Assessment Scheme for Blood Coagulation","volume":"32","author":"Kitchen","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.thromres.2008.10.008_bib15","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1055\/s-2006-947864","article-title":"External peer review quality assurance testing in von Willebrand disease: the recent experience of the United States College of American Pathologists proficiency testing program","volume":"32","author":"Hayes","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.thromres.2008.10.008_bib16","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1111\/j.1538-7836.2008.03090.x","article-title":"Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD) \u2013 a rebuttal","volume":"6","author":"Favaloro","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2008.10.008_bib17","first-page":"178","article-title":"Lower limit of assay sensitivity: an under-recognised and significant problem in von Willebrand disease identification and classification","volume":"21","author":"Favaloro","year":"2008","journal-title":"Clin Lab Sci"},{"key":"10.1016\/j.thromres.2008.10.008_bib18","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1055\/s-2006-949666","article-title":"Management of inherited von Willebrand disease in 2006","volume":"32","author":"Federici","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.thromres.2008.10.008_bib19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2008.10.008_bib20","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1365-2516.2004.00886.x","article-title":"Management of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization","volume":"10","author":"Pasi","year":"2004","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2008.10.008_bib21","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1046\/j.1365-2516.2002.00672.x","article-title":"Italian Association of Hemophilia Centers (AICE). Guidelines for the diagnosis and management of von Willebrand disease in Italy","volume":"8","author":"Federici","year":"2002","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2008.10.008_bib22","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/ajh.2830450303","article-title":"von Willebrand's Disease: Use of Collagen Binding Assay provides potential improvement to laboratory monitoring of desmopressin (DDAVP) therapy","volume":"45","author":"Favaloro","year":"1994","journal-title":"Am J Hematol"},{"key":"10.1016\/j.thromres.2008.10.008_bib23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-2002-27814","article-title":"Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications","volume":"28","author":"Michiels","year":"2002","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.thromres.2008.10.008_bib24","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/1076029606291401","article-title":"Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD","volume":"12","author":"Michiels","year":"2006","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.thromres.2008.10.008_bib25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/1076029606296399","article-title":"Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3","volume":"13","author":"Michiels","year":"2007","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.thromres.2008.10.008_bib26","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1182\/blood-2003-06-2072","article-title":"Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study","volume":"103","author":"Federici","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2008.10.008_bib27","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1182\/blood-2007-08-109231","article-title":"Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD","volume":"111","author":"Castaman","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2008.10.008_bib28","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2516.2004.00894.x","article-title":"The diagnosis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization","volume":"10","author":"Laffan","year":"2004","journal-title":"Haemophilia"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384808004945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384808004945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T22:01:37Z","timestamp":1557957697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384808004945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0049384808004945"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2008.10.008","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}